Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
P/S ratio for Spectrum Pharmaceuticals (SPPI)
P/S ratio as of September 2023 (TTM): 8.22
According to Spectrum Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.21654. At the end of 2023 the company had a P/S ratio of 6.27.
P/S ratio history for Spectrum Pharmaceuticals from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.27 | -15.38% |
| 2022 | 7.40 | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | -100% |
| 2018 | 8.85 | -40.48% |
| 2017 | 14.9 | 509.8% |
| 2016 | 2.44 | -3.71% |
| 2015 | 2.53 | 3.43% |
| 2014 | 2.45 | -32.78% |
| 2013 | 3.64 | 7.7% |
| 2012 | 3.38 | -22.35% |
| 2011 | 4.35 | -8.75% |
| 2010 | 4.77 | -16.51% |
| 2009 | 5.71 | 286.02% |
| 2008 | 1.48 | -86.63% |
| 2007 | 11.1 | -52.28% |
| 2006 | 23.2 | -82.22% |
| 2005 | 130 | 66.23% |
| 2004 | 78.5 | 265.97% |
| 2003 | 21.4 | 936.47% |
| 2002 | 2.07 | -99.9% |
| 2001 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.13 | -49.76% | 🇺🇸 USA |
 Novartis NVS | 3.96 | -51.82% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.37 | -71.14% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.24 | -48.35% | 🇺🇸 USA |
 Biogen BIIB | 3.76 | -54.25% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.73 | -66.79% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.21 | -73.16% | 🇬🇧 UK |
 Seagen
SGEN | 18.6 | 125.80% | 🇺🇸 USA |
 Curis CRIS | 5.23 | -36.29% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.7811 | -90.49% | 🇮🇱 Israel |